Atlas Trials

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

Clinical trial NCT05761938 · UNKNOWN

Trial details

NCT number
NCT05761938
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Study type
OBSERVATIONAL
Glomerulonephritis
Start date
2023-02-01
Primary completion
2024-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.